Evidence map›Paper›PMID 28183447›Full record

ArticleMetabolism: clinical and experimental2017

Acute low-dose endotoxin treatment results in improved whole-body glucose homeostasis in mice.

Joseph R Stevens, Ryan P McMillan, Justin T Resendes, Shannon K Lloyd, Mostafa M Ali, Madlyn I Frisard, Stefan Hargett, Susanna R Keller, Matthew W Hulver

Abstract read
In one paragraph

Article in Metabolism: clinical and experimental, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Joseph R StevensDepartment of Human Nutrition, Foods, and Exercise, Virginia Tech, Blacksburg, VA.
Ryan P McMillanDepartment of Human Nutrition, Foods, and Exercise, Virginia Tech, Blacksburg, VA; Metabolic Phenotyping Core, Virginia Tech, Blacksburg, VA.
Justin T ResendesDepartment of Human Nutrition, Foods, and Exercise, Virginia Tech, Blacksburg, VA.
Shannon K LloydDepartment of Human Nutrition, Foods, and Exercise, Virginia Tech, Blacksburg, VA.
Mostafa M AliDepartment of Human Nutrition, Foods, and Exercise, Virginia Tech, Blacksburg, VA.
Madlyn I FrisardDepartment of Human Nutrition, Foods, and Exercise, Virginia Tech, Blacksburg, VA.
Stefan HargettDepartment of Medicine/Division of Endocrinology, University of Virginia, Charlottesville, VA.
Susanna R KellerDepartment of Medicine/Division of Endocrinology, University of Virginia, Charlottesville, VA.
Matthew W HulverDepartment of Human Nutrition, Foods, and Exercise, Virginia Tech, Blacksburg, VA; Metabolic Phenotyping Core, Virginia Tech, Blacksburg, VA. Electronic address: hulvermw@vt.edu.
Virginia Tech · USUniversity of Virginia · US

Funding

Inflammatory Regulation of Lipid Accumulation in Skeletal Muscle with ObesityR01DK078765 · NIDDK · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI HULVER, MATTHEW W · 2008 to 2012
$1.7M
Inflammatory regulation of lipid accumulation in skeletal muscle with obesityR56DK078765 · NIDDK · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI HULVER, MATTHEW W · 2007 to 2007
$157k
NIDDK NIH HHS R01 DK078765NIDDK NIH HHS R56 DK078765
6 · The paper itself

Abstract

backgroundObese individuals present with an increased inflammatory tone as compared to healthy, normal-weight individuals, which is associated with insulin resistance. One factor hypothesized to contribute to increased inflammation in obese and diabetic states is elevated blood endotoxin levels, a condition known as metabolic endotoxemia. In non-obese and insulin sensitive individuals, circulating endotoxin concentrations fluctuate over the course of the day with elevations in the post-prandial state that return to baseline levels in the post-absorptive state. Evidence suggests that high-fat feeding alters these fluctuations causing endotoxin levels to remain high throughout the day. The effects of alterations in endotoxin levels on glucose metabolism are not clearly understood. PURPOSE/PROCEDURES: The goal of this study was to determine the effects of both short-term and long-term increases in endotoxin (lipopolysaccharide, LPS) of a low magnitude on the glucose tolerance and insulin signaling in a human primary cell line as well as the effects of short-term endotoxin treatments on glucose homeostasis in a C57/Bl6 mouse model. First, we tested the hypothesis that short-term low-dose endotoxin treatments would augment insulin signaling and glycogen synthesis while long-term treatments would be disruptive in the cell culture model. Second, we examined if these short-term low dose treatments of endotoxin would contribute to similar improvements in whole-body glucose homeostasis in a mouse model. MAIN

findingsContrary to our initial hypothesis, short-term endotoxin treatment had no effect on insulin signaling or glycogen synthesis, however long-term treatment indeed decreased glycogen synthesis (P<.05). Interestingly, short-term endotoxin treatment resulted in significant improvements in glucose homeostasis in the mouse model (P<.01); which is believed to be at least partly attributed to an inhibitory action of LPS on liver glucose production.

conclusionsThis research shows that low-magnitude, short-term changes in LPS can have significant effects on whole body glucose metabolism and this likely occurs through its direct actions on the liver. Additional studies are necessary to understand the mechanisms responsible for altered glucose metabolism in response to low magnitude changes in LPS levels.

Indexed as

AnimalsCell LineEndotoxinsGluconeogenesisGlucoseGlucose Tolerance TestGlucose Transporter Type 4GlycogenHomeostasisHumansInsulinLipopolysaccharidesLiverMaleMiceMice, Inbred C57BLEndotoxinsGlucoseGlucose Transporter Type 4GlycogenInsulinLipopolysaccharidesSlc2a4 protein, mouseEndotoxinGlucose homeostasisLPSMetabolic endotoxemiaSkeletal muscle

Identifiers

PMID28183447
PMCPMC5319723
OpenAlexW2567111941

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.